BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FOXP1
,
T cell differentiation
,
Ischemia
,
Intestine
,
Autoimmunity
,
Lipopolysaccharide
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
modulation by virus of host process
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Duodenum
Heart
Globus pallidus
Vena cava
Thymus gland
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Placental insufficiency
Multiple-resistant Staphylococcus aureus infection
Pyloric ulcer
Vesicular stomatitis Indiana virus disease
Caseating tuberculoid granuloma
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
combretastatin A-4
temsirolimus
flavopiridol
CGP 60474
A 443654
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
hsa-miR-365a-3p
PCDH11X
FUBP3
CTSK
DIDO1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
Circulating miRNA in serum of Wilms tumor patients
Colorectal cancers subtypes miRNA profiles
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for modulation by virus of host process
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pomalidomide for Chronic Graft-versus-Host Disease
CC-4047 (Pomalidomide) for Graft vs. Host Disease
PTM202 and Modulation of Host Resistance to Diarrheagenic E. Coli
Theralux Extracorporeal Photochemotherapy (ECP) in Patients With Extensive Chronic Graft Versus Host…
Prospective Study to Characterize Host-pathogen Related Factors in Hospitalized and ED Patients With…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ